Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ramsden

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
Frontiers in Neuroscience|September 8, 2017
Interim Results of a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherited Retinal DegenerationsKatarina Stingl, Ruth Schippert, Karl U Bartz-Schmidt, et al.
Vision Research|March 28, 2015
Subretinal Visual Implant Alpha IMS--Clinical trial interim reportKatarina Stingl, Karl Ulrich Bartz-Schmidt, Dorothea Besch, et al.
Journal of Medicinal Chemistry|September 25, 2007
Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesityJoachim Rudolph, William P Esler, Stephen O'connor, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
Frontiers in Neuroscience|September 8, 2017
Interim Results of a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherited Retinal DegenerationsKatarina Stingl, Ruth Schippert, Karl U Bartz-Schmidt, et al.
Vision Research|March 28, 2015
Subretinal Visual Implant Alpha IMS--Clinical trial interim reportKatarina Stingl, Karl Ulrich Bartz-Schmidt, Dorothea Besch, et al.
Journal of Medicinal Chemistry|September 25, 2007
Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesityJoachim Rudolph, William P Esler, Stephen O'connor, et al.
Pageof 12